These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21601607)

  • 1. Characterizing non-constant relative potency.
    Dinse GE; Umbach DM
    Regul Toxicol Pharmacol; 2011 Aug; 60(3):342-53. PubMed ID: 21601607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameterizing dose-response models to estimate relative potency functions directly.
    Dinse GE; Umbach DM
    Toxicol Sci; 2012 Oct; 129(2):447-55. PubMed ID: 22700543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology rethinks its central belief.
    Calabrese EJ; Baldwin LA
    Nature; 2003 Feb; 421(6924):691-2. PubMed ID: 12610596
    [No Abstract]   [Full Text] [Related]  

  • 4. A Unified Probabilistic Framework for Dose-Response Assessment of Human Health Effects.
    Chiu WA; Slob W
    Environ Health Perspect; 2015 Dec; 123(12):1241-54. PubMed ID: 26006063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human biomonitoring assessment values: approaches and data requirements.
    Angerer J; Aylward LL; Hays SM; Heinzow B; Wilhelm M
    Int J Hyg Environ Health; 2011 Sep; 214(5):348-60. PubMed ID: 21764371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical inferences on nonconstant relative potency with quantal response data.
    Kerns LX
    Biom J; 2021 Apr; 63(4):825-840. PubMed ID: 33410246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alleged misconceptions' distort perceptions of environmental cancer risks.
    Tomatis L; Melnick RL; Haseman J; Barrett JC; Huff J
    FASEB J; 2001 Jan; 15(1):195-203. PubMed ID: 11149907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic or applied, it's the interaction that counts.
    Farmer PB
    Nature; 2002 May; 417(6885):117. PubMed ID: 12000933
    [No Abstract]   [Full Text] [Related]  

  • 11. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental design constraints on carcinogenic potency estimates.
    Rieth JP; Starr TB
    J Toxicol Environ Health; 1989; 27(3):287-96. PubMed ID: 2754755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory aspects of genotoxicity testing: from hazard identification to risk assessment.
    Blakey D; Galloway SM; Kirkland DJ; MacGregor JT
    Mutat Res; 2008 Nov; 657(1):84-90. PubMed ID: 18926925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Inherent Toxicity Concept in Environmental Toxicology and Risk Assessment.
    McCarty LS; Borgert CJ; Burgoon LD
    Environ Toxicol Chem; 2020 Dec; 39(12):2351-2360. PubMed ID: 32986269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fundamentals are still relevant in toxicology.
    Eaton DL; Greenlee WF
    Nature; 2002 May; 417(6885):117. PubMed ID: 12000934
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond the RfD: Broad Application of a Probabilistic Approach to Improve Chemical Dose-Response Assessments for Noncancer Effects.
    Chiu WA; Axelrad DA; Dalaijamts C; Dockins C; Shao K; Shapiro AJ; Paoli G
    Environ Health Perspect; 2018 Jun; 126(6):067009. PubMed ID: 29968566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating comparative potencies: developing approaches to risk assessment of chemical mixtures.
    Schoeny RS; Margosches E
    Toxicol Ind Health; 1989 Oct; 5(5):825-37. PubMed ID: 2683225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative cancer risk assessment for occupational exposures to asphalt fumes during built-up roofing asphalt (BURA) operations.
    Rhomberg LR; Mayfield DB; Goodman JE; Butler EL; Nascarella MA; Williams DR
    Crit Rev Toxicol; 2015; 45(10):873-918. PubMed ID: 26515283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.